Decline in age-adjusted suicide rate from 2018 to 2020 followed by increases in 2021 and 2022
Findings seen for attention-deficit/hyperactivity disorder or depressive disorder
No increased rates of positive M-CHAT-R screening seen for offspring
Likelihood of offering medications for OUD higher for jails with shorter mean distances to nearest facility providing MOUD
Compared with other antidiabetes medications, semaglutide linked to lower risk for patients with comorbid opioid use disorder
Active suicidal ideation higher for cisgender males than females
Association exists in a sex- and childhood stressor-specific manner
Increased risk seen for mortality and for hospitalization, acute kidney injury, chronic kidney disease, bone fracture, bowel obstruction









